Sign in
4

Changes in Ownership

Taysha Gene Therapies, Inc. Filed Acc 0001209191-20-052462

Director acquired 1,091,101 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Nolan Sean P. Director 2020-09-28 Conversion +1,089,500 1,089,500 I
Nolan Sean P. Director 2020-09-28 Conversion +1,601 1,091,101 I
Derivatives
Nolan Sean P. Director 2020-09-28 Conversion · Series A Preferred Stock −1,000,000 0 I
Nolan Sean P. Director 2020-09-28 Conversion · Series B Preferred Stock −1,470 0 I
Loading xslF345X03/doc4.xml…